Its tumorigenic potential has been demonstrated in animal models [22] and is supported by the finding of over-expression of BCL2 in a variety of tumours and in lymphomas in which BCL2 acts as an oncogene [23,24]. This evidence concerns the gene BCL2 and neoplasm.